82_FR_26221 82 FR 26114 - Agency Information Collection Activities: Submission for OMB Review; Comment Request

82 FR 26114 - Agency Information Collection Activities: Submission for OMB Review; Comment Request

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 82, Issue 107 (June 6, 2017)

Page Range26114-26116
FR Document2017-11632

Federal Register, Volume 82 Issue 107 (Tuesday, June 6, 2017)
[Federal Register Volume 82, Number 107 (Tuesday, June 6, 2017)]
[Notices]
[Pages 26114-26116]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-11632]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the

[[Page 26115]]

Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of 
these documents, call the SAMHSA Reports Clearance Officer on (240) 
276-1243.

Project: Notification of Intent To Use Schedule III, IV, or V Opioid 
Drugs for the Maintenance and Detoxification Treatment of Opiate 
Addiction by a ``Qualifying Other Practitioner''--(OMB No. 0930-0369)--
Revision

    The Substance Abuse and Mental Health Services Administration 
(SAMHSA) is requesting a revision from the Office of Management and 
Budget (OMB) for approval of the Notification of Intent to Use Schedule 
III, IV, or V Opioid Drugs for the Maintenance and Detoxification 
Treatment of Opiate Addiction by a ``Qualifying Other Practitioner.'' 
The Notification of Intent would allow SAMHSA to determine whether 
other practitioners are eligible to prescribe certain approved narcotic 
treatment medications for the maintenance or detoxification treatment 
of opioid addiction.
    This Notification of Intent is a result of the Comprehensive 
Addiction and Recovery Act (Pub. L. 114-198), which was signed into law 
on July 22, 2016. The law establishes criteria for nurse practitioners 
(NPs) and physician assistants (PAs) to qualify for a waiver to 
prescribe covered medications. To be eligible for a waiver, the NP or 
PA must: Be licensed under State law to prescribe schedule III, IV, or 
V medications for the treatment of pain; fulfill qualification 
requirements in the law for training and experience; and fulfill 
qualification requirements in the law for appropriate supervision by a 
qualifying physician. SAMHSA has the responsibility to receive, review, 
approve, or deny waiver requests.
    Practitioners who meet the statutory requirements will be eligible 
to prescribe only those opioid treatment medications that are 
controlled in Schedules III, IV, or V, under the Controlled Substance 
Act (CSA), that are specifically approved by the Food and Drug 
Administration (FDA) for the treatment of opioid addiction, and are not 
the subject of an ``adverse determination.'' The only medications that 
currently fulfill these requirements are ones that contain the active 
ingredient buprenorphine.
    Below are the following changes:

Address of Practice Location (NOI Item 2 and Instructions Section)

    The newly revised instructions in Section 2 now acknowledge that 
practitioners may practice at multiple practice locations, but may only 
list a practice location address that matches their DEA registration 
practice site. Furthermore, the revised section provides a link where 
practitioners may add additional practice sites.

Use of Term of ``Other Qualifying Practitioners'' (See NOI Items 1, 2, 
6, and 11)

    The Statute section 823(g)(2)(B)(i) refers to both physicians and 
mid-level providers as ``qualifying practitioners.'' Therefore in order 
to avoid confusion and redundancy the revised NOI Instructions Section 
refers to ``other qualifying practitioners,'' simply as 
``practitioners.''

Use of Term of ``Supervisory Physician or Collaborative Physician'' 
(NOI Item 8)

    The third and fourth criteria in this section created confusion 
regarding the relationship with a qualifying physician since providers 
are required to be supervised by OR work with a collaborative 
physician, but not both. Therefore, the word ``and'' was replaced by 
``or''.

Patient Limits (Item 6: Purpose of Notification)

    Language was added allowing practitioners who have treated 30 
patients for at least one year to increase their patient limit to 100. 
This second notification to treat 100 patients was omitted in the 
original NOI form.

Use of Term of ``Qualifying Physician'' (NOI Item 8)

    The Controlled Substance Act (CSA) requires that NPs and PAs be 
supervised (or collaborate with) a ``qualifying physician'' when 
required by state law to work with a supervising physician (see 21 
U.S.C. 823(g)(2)(G)(iv)(III)). SAMHSA added a footnote with a 
definition of the term ``qualifying physician'' means in the context of 
the NOI. The term ``qualifying physician'' is specifically defined 
under 21 U.S.C. 823(g)(2)(G)(ii).

Certification of Qualifying Criteria (NOI Item 8)

    The law specifically authorizes NPs and PAs as eligible to apply to 
be a ``Qualifying Other Practitioner.'' However, the proposed 
Notification of Intent form asks applicants to certify that they are 
either an ``advanced practice nurse or physician assistant.'' This 
difference in terminology was considered confusing to potential 
applicants. SAMHSA revised the first attestation in Certification of 
Qualifying Criteria to read ``I certify that I am either a nurse 
practitioner or physician assistant who satisfies the definition of a 
`qualifying other practitioner.''

Identification of Training Providers (NOI Item 8)

    The previous NOI required that the practitioner to write-in the 
name of training provider(s)' name(s). The revised NOI allows 
practitioners to select all applicable training providers from a drop 
down list.

Certification of Capacity (NOI Item 9)

    The second attestation in this section was missing a verb. SAMHSA 
corrected this error to reflect the statutory language requiring 
qualifying practitioners to attest to the capacity to provide directly 
or by referral.

Certification of Maximum Patient Load (NOI Item 10)

    It was clarified that the second option regarding increasing 
patient load to 100 refers to a second notifications (as specified in 
the analogous NOI form for physicians).

Privacy Act Information

    This section noted that medical specialty societies be used to 
verify practitioner credentials. The revised NOI replaced the words 
``medical specialty societies'' with ``relevant licensing boards to 
verify practitioners' qualifications.''
    The following table is the estimated hour burden:

----------------------------------------------------------------------------------------------------------------
                                                     Number of      Responses/                     Total burden
              Purpose of submission                 respondents     respondent     Burden hours        hours
----------------------------------------------------------------------------------------------------------------
Notification of Intent for Qualifying Other                  816               1            .066              54
 Practitioner to Use Schedule III, IV, or V
 Opioid Drugs for the Maintenance and
 Detoxification Treatment of Opiate Addiction by
 a ``Qualifying Other Practitioner'' under 21
 U.S.C. 823(g)(2)--Nurse Practitioners..........

[[Page 26116]]

 
Notification of Intent for Qualifying Other                  590               1            .066              39
 Practitioner to Use Schedule III, IV, or V
 Opioid Drugs for the Maintenance and
 Detoxification Treatment of Opiate Addiction by
 a ``Qualifying Other Practitioner'' under 21
 U.S.C. 823(g)(2)--Physician Assistants.........
                                                 ---------------------------------------------------------------
    Total.......................................           1,406  ..............  ..............              93
----------------------------------------------------------------------------------------------------------------

    Written comments and recommendations concerning the proposed 
information collection should be sent by July 6, 2017 to the SAMHSA 
Desk Officer at the Office of Information and Regulatory Affairs, 
Office of Management and Budget (OMB). To ensure timely receipt of 
comments, and to avoid potential delays in OMB's receipt and processing 
of mail sent through the U.S. Postal Service, commenters are encouraged 
to submit their comments to OMB via email to: 
[email protected]. Although commenters are encouraged to send 
their comments via email, commenters may also fax their comments to: 
202-395-7285. Commenters may also mail them to: Office of Management 
and Budget, Office of Information and Regulatory Affairs, New Executive 
Office Building, Room 10102, Washington, DC 20503.

Summer King,
Statistician.
[FR Doc. 2017-11632 Filed 6-5-17; 8:45 am]
 BILLING CODE 4162-20-P



                                                  26114                           Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices

                                                    Contact Person: Tatiana V. Cohen, Ph.D.,                Name of Committee: Center for Scientific               Place: National Institutes of Health, 6701
                                                  Scientific Review Officer, Center for                   Review Special Emphasis Panel;                         Rockledge Drive, Bethesda, MD 20892
                                                  Scientific Review, National Institutes of               Fellowships: Physiology and Pathobiology of            (Telephone Conference Call).
                                                  Health, 6701 Rockledge Drive Room 5213,                 Musculoskeletal, Oral and Skin Systems.                  Contact Person: Deborah L. Lewis, Ph.D.,
                                                  Bethesda, MD 20892, 301–455–2364,                         Date: June 28, 2017.                                 Scientific Review Officer, Center for
                                                  tatiana.cohen@nih.gov.                                    Time: 10:00 a.m. to 5:00 p.m.                        Scientific Review, National Institutes of
                                                    Name of Committee: Center for Scientific                Agenda: To review and evaluate grant                 Health, 6701 Rockledge Drive, Room 4183,
                                                  Review Special Emphasis Panel; Infectious,              applications.                                          MSC 7850, Bethesda, MD 20892, 301–408–
                                                  Reproductive, Asthma and Pulmonary                        Place: National Institutes of Health, 6701           9129, lewisdeb@csr.nih.gov.
                                                  Conditions: Additional Applications.                    Rockledge Drive, Bethesda, MD 20892.                     Name of Committee: Center for Scientific
                                                    Date: June 28, 2017.                                    Contact Person: Anshumali Chaudhari,                 Review Special Emphasis Panel; Member
                                                    Time: 8:00 a.m. to 4:00 p.m.                          Ph.D., Scientific Review Officer, Center for           Conflict: Toxicology.
                                                    Agenda: To review and evaluate grant                  Scientific Review, National Institutes of                Date: June 28, 2017.
                                                  applications.                                           Health, 6701 Rockledge Drive, Room 4124,                 Time: 1:00 p.m. to 3:00 p.m.
                                                    Place: Wyndham Grand Chicago                          MSC 7802, Bethesda, MD 20892, (301) 435–                 Agenda: To review and evaluate grant
                                                  Riverfront, 71 East Wacker Drive, Chicago, IL           1210, chaudhaa@csr.nih.gov.                            applications.
                                                  60601.                                                                                                           Place: National Institutes of Health, 6701
                                                                                                            Name of Committee: Center for Scientific             Rockledge Drive, Bethesda, MD 20892
                                                    Contact Person: Suzanne Ryan, Ph.D.,                  Review Special Emphasis Panel; Small
                                                  Scientific Review Officer, Center for                                                                          (Telephone Conference Call).
                                                                                                          Business: Musculoskeletal Rehabilitations                Contact Person: Jonathan K. Ivins, Ph.D.,
                                                  Scientific Review, National Institutes of               Sciences.
                                                  Health, 6701 Rockledge Drive, Room 3139,                                                                       Scientific Review Officer, Center for
                                                                                                            Date: June 28, 2017.                                 Scientific Review, National Institutes of
                                                  MSC 7770, Bethesda, MD 20892, (301) 435–                  Time: 10:00 a.m. to 4:00 p.m.
                                                  1712, ryansj@csr.nih.gov.                                                                                      Health, 6701 Rockledge Drive, Room 4040A,
                                                                                                            Agenda: To review and evaluate grant                 MSC 7806, Bethesda, MD 20892, (301) 594–
                                                    Name of Committee: Population Sciences                applications.                                          1245, ivinsj@csr.nih.gov.
                                                  and Epidemiology Integrated Review Group;                 Place: National Institutes of Health, 6701
                                                  Infectious Diseases, Reproductive Health,                                                                        Name of Committee: Center for Scientific
                                                                                                          Rockledge Drive, Bethesda, MD 20892.
                                                  Asthma and Pulmonary Conditions Study                                                                          Review Special Emphasis Panel; RFA Panel:
                                                                                                            Contact Person: Maria Nurminskaya, Ph.D.,            Interdisciplinary Research to Understand the
                                                  Section.                                                Scientific Review Officer, Center for
                                                    Date: June 28–29, 2017.                                                                                      Complex Biology of Resilience to
                                                                                                          Scientific Review, National Institutes of              Alzheimer’s Disease Risk (R01).
                                                    Time: 8:00 a.m. to 5:00 p.m.                          Health, Bethesda, MD 20892, (301) 435–1222,
                                                    Agenda: To review and evaluate grant                                                                           Date: June 28, 2017.
                                                                                                          nurminskayam@csr.nih.gov.                                Time: 12:00 p.m. to 3:00 p.m.
                                                  applications.
                                                                                                            Name of Committee: Center for Scientific               Agenda: To review and evaluate grant
                                                    Place: Wyndham Grand Chicago
                                                                                                          Review Special Emphasis Panel; PAR Panel:              applications.
                                                  Riverfront, 71 East Wacker Drive, Chicago, IL
                                                                                                          Systems Science and Health in the                        Place: National Institutes of Health, 6701
                                                  60601.
                                                                                                          Behavioral and Social Science.                         Rockledge Drive, Bethesda, MD 20892
                                                    Contact Person: Lisa Steele, Ph.D.,
                                                  Scientific Review Officer, Center for                     Date: June 28, 2017.                                 (Virtual Meeting).
                                                  Scientific Review, National Institutes of                 Time: 1:00 p.m. to 6:00 p.m.                           Contact Person: Jonathan Arias, Ph.D.,
                                                  Health, 6701 Rockledge Drive, Room 3139,                  Agenda: To review and evaluate grant                 Scientific Review Officer, Center for
                                                                                                          applications.                                          Scientific Review, National Institutes of
                                                  MSC 7770, Bethesda, MD 20892, (301) 257–
                                                                                                            Place: National Institutes of Health, 6701           Health, 6701 Rockledge Drive, Room 5170,
                                                  2638, steeleln@csr.nih.gov.
                                                                                                          Rockledge Drive, Bethesda, MD 20892                    MSC 7840, Bethesda, MD 20892, 301–435–
                                                    Name of Committee: Center for Scientific              (Telephone Conference Call).                           2406, ariasj@csr.nih.gov.
                                                  Review Special Emphasis Panel; PAR–16–                    Contact Person: Ping Wu, Ph.D., Scientific
                                                  407: Emerging Epidemic Virus Research                                                                          (Catalogue of Federal Domestic
                                                                                                          Review Officer, HDM IRG, Center for                    Assistance Program Nos. 93.306,
                                                  Training.                                               Scientific Review, National Institutes of
                                                    Date: June 28, 2017.                                                                                         Comparative Medicine; 93.333, Clinical
                                                                                                          Health, 6701 Rockledge Drive, Room 3166,
                                                    Time: 10:00 a.m. to 5:00 p.m.                                                                                Research, 93.306, 93.333, 93.337,
                                                                                                          Bethesda, MD 20892, 301–451–8428, wup4@
                                                    Agenda: To review and evaluate grant
                                                                                                          csr.nih.gov.
                                                                                                                                                                 93.393–93.396, 93.837–93.844, 93.846–
                                                  applications.                                                                                                  93.878, 93.892, 93.893, National
                                                    Place: National Institutes of Health, 6701              Name of Committee: Center for Scientific
                                                                                                          Review Special Emphasis Panel; PAR17–029:
                                                                                                                                                                 Institutes of Health, HHS)
                                                  Rockledge Drive, Bethesda, MD 20892
                                                  (Telephone Conference Call).                            Dynamic Interactions between Systemic or                 Dated: May 31, 2017.
                                                    Contact Person: Kenneth M. Izumi, Ph.D.,              Non-Neuronal Systems and the Brain in                  David Clary,
                                                  Scientific Review Officer, Center for                   Aging and in Alzheimer’s Disease.                      Program Analyst, Office of Federal Advisory
                                                  Scientific Review, National Institutes of                 Date: June 28, 2017.                                 Committee Policy.
                                                  Health, 6701 Rockledge Drive, Room 3204,                  Time: 1:00 p.m. to 6:00 p.m.
                                                                                                                                                                 [FR Doc. 2017–11590 Filed 6–5–17; 8:45 am]
                                                  MSC 7808, Bethesda, MD 20892, 301–496–                    Agenda: To review and evaluate grant
                                                                                                          applications.                                          BILLING CODE 4140–01–P
                                                  6980, izumikm@csr.nih.gov.
                                                    Name of Committee: Center for Scientific                Place: National Institutes of Health, 6701
                                                  Review Special Emphasis Panel; Fellowship:              Rockledge Drive, Bethesda, MD 20892
                                                                                                          (Telephone Conference Call).                           DEPARTMENT OF HEALTH AND
                                                  Surgical Sciences Biomedical Imaging and
                                                  Bioengineering.                                           Contact Person: Inese Z. Beitins, MD,                HUMAN SERVICES
                                                    Date: June 28, 2017.                                  Scientific Review Officer, Center for
                                                    Time: 10:00 a.m. to 6:00 p.m.                         Scientific Review, National Institutes of              Substance Abuse and Mental Health
                                                    Agenda: To review and evaluate grant                  Health, 6701 Rockledge Drive, Room 6152,               Services Administration
                                                  applications.                                           MSC 7892, Bethesda, MD 20892, 301–435–
                                                    Place: National Institutes of Health, 6701            1034, beitinsi@csr.nih.gov.                            Agency Information Collection
mstockstill on DSK30JT082PROD with NOTICES




                                                  Rockledge Drive, Bethesda, MD 20892                       Name of Committee: Center for Scientific             Activities: Submission for OMB
                                                  (Virtual Meeting).                                      Review Special Emphasis Panel; Member                  Review; Comment Request
                                                    Contact Person: Donald Scott Wright,                  Conflict: Neuronal and Glia Function in
                                                  Ph.D., Scientific Review Officer, Center for            Neurological Disorders.                                  Periodically, the Substance Abuse and
                                                  Scientific Review, National Institutes of                 Date: June 28, 2017.                                 Mental Health Services Administration
                                                  Health, 6701 Rockledge Drive, Room 5108,                  Time: 1:00 p.m. to 3:30 p.m.                         (SAMHSA) will publish a summary of
                                                  MSC 7854, Bethesda, MD 20892, (301) 435–                  Agenda: To review and evaluate grant                 information collection requests under
                                                  8363, wrightds@csr.nih.gov.                             applications.                                          OMB review, in compliance with the


                                             VerDate Sep<11>2014   20:52 Jun 05, 2017   Jkt 241001   PO 00000   Frm 00073   Fmt 4703   Sfmt 4703   E:\FR\FM\06JNN1.SGM   06JNN1


                                                                                       Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices                                                      26115

                                                  Paperwork Reduction Act (44 U.S.C.                              are ones that contain the active                           NOI. The term ‘‘qualifying physician’’ is
                                                  Chapter 35). To request a copy of these                         ingredient buprenorphine.                                  specifically defined under 21 U.S.C.
                                                  documents, call the SAMHSA Reports                                Below are the following changes:                         823(g)(2)(G)(ii).
                                                  Clearance Officer on (240) 276–1243.                            Address of Practice Location (NOI Item                     Certification of Qualifying Criteria (NOI
                                                  Project: Notification of Intent To Use                          2 and Instructions Section)                                Item 8)
                                                  Schedule III, IV, or V Opioid Drugs for                           The newly revised instructions in
                                                  the Maintenance and Detoxification                                                                                            The law specifically authorizes NPs
                                                                                                                  Section 2 now acknowledge that                             and PAs as eligible to apply to be a
                                                  Treatment of Opiate Addiction by a                              practitioners may practice at multiple
                                                  ‘‘Qualifying Other Practitioner’’—(OMB                                                                                     ‘‘Qualifying Other Practitioner.’’
                                                                                                                  practice locations, but may only list a                    However, the proposed Notification of
                                                  No. 0930–0369)—Revision                                         practice location address that matches                     Intent form asks applicants to certify
                                                     The Substance Abuse and Mental                               their DEA registration practice site.                      that they are either an ‘‘advanced
                                                  Health Services Administration                                  Furthermore, the revised section                           practice nurse or physician assistant.’’
                                                  (SAMHSA) is requesting a revision from                          provides a link where practitioners may                    This difference in terminology was
                                                  the Office of Management and Budget                             add additional practice sites.
                                                                                                                                                                             considered confusing to potential
                                                  (OMB) for approval of the Notification                          Use of Term of ‘‘Other Qualifying                          applicants. SAMHSA revised the first
                                                  of Intent to Use Schedule III, IV, or V                         Practitioners’’ (See NOI Items 1, 2, 6,                    attestation in Certification of Qualifying
                                                  Opioid Drugs for the Maintenance and                            and 11)                                                    Criteria to read ‘‘I certify that I am either
                                                  Detoxification Treatment of Opiate                                                                                         a nurse practitioner or physician
                                                  Addiction by a ‘‘Qualifying Other                                  The Statute section 823(g)(2)(B)(i)
                                                                                                                  refers to both physicians and mid-level                    assistant who satisfies the definition of
                                                  Practitioner.’’ The Notification of Intent                                                                                 a ‘qualifying other practitioner.’’
                                                  would allow SAMHSA to determine                                 providers as ‘‘qualifying practitioners.’’
                                                  whether other practitioners are eligible                        Therefore in order to avoid confusion                      Identification of Training Providers
                                                  to prescribe certain approved narcotic                          and redundancy the revised NOI                             (NOI Item 8)
                                                  treatment medications for the                                   Instructions Section refers to ‘‘other
                                                                                                                  qualifying practitioners,’’ simply as                         The previous NOI required that the
                                                  maintenance or detoxification treatment                                                                                    practitioner to write-in the name of
                                                  of opioid addiction.                                            ‘‘practitioners.’’
                                                                                                                                                                             training provider(s)’ name(s). The
                                                     This Notification of Intent is a result                      Use of Term of ‘‘Supervisory Physician                     revised NOI allows practitioners to
                                                  of the Comprehensive Addiction and                              or Collaborative Physician’’ (NOI Item 8)                  select all applicable training providers
                                                  Recovery Act (Pub. L. 114–198), which
                                                                                                                    The third and fourth criteria in this                    from a drop down list.
                                                  was signed into law on July 22, 2016.
                                                                                                                  section created confusion regarding the
                                                  The law establishes criteria for nurse                                                                                     Certification of Capacity (NOI Item 9)
                                                                                                                  relationship with a qualifying physician
                                                  practitioners (NPs) and physician                               since providers are required to be
                                                  assistants (PAs) to qualify for a waiver                                                                                     The second attestation in this section
                                                                                                                  supervised by OR work with a                               was missing a verb. SAMHSA corrected
                                                  to prescribe covered medications. To be                         collaborative physician, but not both.
                                                  eligible for a waiver, the NP or PA must:                                                                                  this error to reflect the statutory
                                                                                                                  Therefore, the word ‘‘and’’ was replaced                   language requiring qualifying
                                                  Be licensed under State law to prescribe                        by ‘‘or’’.
                                                  schedule III, IV, or V medications for the                                                                                 practitioners to attest to the capacity to
                                                  treatment of pain; fulfill qualification                        Patient Limits (Item 6: Purpose of                         provide directly or by referral.
                                                  requirements in the law for training and                        Notification)                                              Certification of Maximum Patient Load
                                                  experience; and fulfill qualification                             Language was added allowing                              (NOI Item 10)
                                                  requirements in the law for appropriate                         practitioners who have treated 30
                                                  supervision by a qualifying physician.                                                                                       It was clarified that the second option
                                                                                                                  patients for at least one year to increase
                                                  SAMHSA has the responsibility to                                                                                           regarding increasing patient load to 100
                                                                                                                  their patient limit to 100. This second
                                                  receive, review, approve, or deny waiver                                                                                   refers to a second notifications (as
                                                                                                                  notification to treat 100 patients was
                                                  requests.                                                                                                                  specified in the analogous NOI form for
                                                                                                                  omitted in the original NOI form.
                                                     Practitioners who meet the statutory                                                                                    physicians).
                                                  requirements will be eligible to                                Use of Term of ‘‘Qualifying Physician’’
                                                                                                                  (NOI Item 8)                                               Privacy Act Information
                                                  prescribe only those opioid treatment
                                                  medications that are controlled in                                The Controlled Substance Act (CSA)                          This section noted that medical
                                                  Schedules III, IV, or V, under the                              requires that NPs and PAs be supervised                    specialty societies be used to verify
                                                  Controlled Substance Act (CSA), that                            (or collaborate with) a ‘‘qualifying                       practitioner credentials. The revised
                                                  are specifically approved by the Food                           physician’’ when required by state law                     NOI replaced the words ‘‘medical
                                                  and Drug Administration (FDA) for the                           to work with a supervising physician                       specialty societies’’ with ‘‘relevant
                                                  treatment of opioid addiction, and are                          (see 21 U.S.C. 823(g)(2)(G)(iv)(III)).                     licensing boards to verify practitioners’
                                                  not the subject of an ‘‘adverse                                 SAMHSA added a footnote with a                             qualifications.’’
                                                  determination.’’ The only medications                           definition of the term ‘‘qualifying                           The following table is the estimated
                                                  that currently fulfill these requirements                       physician’’ means in the context of the                    hour burden:

                                                                                                                                                          Number of        Responses/                        Total burden
                                                                                    Purpose of submission                                                                                     Burden hours
                                                                                                                                                         respondents       respondent                           hours
mstockstill on DSK30JT082PROD with NOTICES




                                                  Notification of Intent for Qualifying Other Practitioner to Use Schedule III,
                                                    IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment
                                                    of Opiate Addiction by a ‘‘Qualifying Other Practitioner’’ under 21 U.S.C.
                                                    823(g)(2)—Nurse Practitioners ....................................................................              816                 1             .066              54




                                             VerDate Sep<11>2014      20:52 Jun 05, 2017     Jkt 241001    PO 00000     Frm 00074     Fmt 4703     Sfmt 4703   E:\FR\FM\06JNN1.SGM   06JNN1


                                                  26116                                     Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices

                                                                                                                                                                           Number of        Responses/                                          Total burden
                                                                                         Purpose of submission                                                                                                       Burden hours
                                                                                                                                                                          respondents       respondent                                             hours

                                                  Notification of Intent for Qualifying Other Practitioner to Use Schedule III,
                                                    IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment
                                                    of Opiate Addiction by a ‘‘Qualifying Other Practitioner’’ under 21 U.S.C.
                                                    823(g)(2)—Physician Assistants ..................................................................                               590                         1                    .066                 39

                                                       Total ..........................................................................................................           1,406   ........................   ........................             93



                                                    Written comments and                                                     ADDRESSES:    Nominations must be in                             the Office of Management and Budget
                                                  recommendations concerning the                                             writing and submitted via email to                               (OMB).1
                                                  proposed information collection should                                     HCFAC.application@hud.gov.                                         The HCFAC shall consist of not more
                                                  be sent by July 6, 2017 to the SAMHSA                                      Individuals that do not have internet                            than 12 individuals appointed by the
                                                  Desk Officer at the Office of Information                                  access may submit nominations to                                 Secretary. The membership will equally
                                                  and Regulatory Affairs, Office of                                          Marjorie George, Housing Program                                 represent the mortgage industry, real
                                                  Management and Budget (OMB). To                                            Technical Specialist, U.S. Department of                         estate industry, consumers, and HUD-
                                                  ensure timely receipt of comments, and                                     Housing and Urban Development, Office                            approved housing counseling agencies.
                                                  to avoid potential delays in OMB’s                                         of Housing Counseling, Office of                                 Each member shall be appointed in his
                                                  receipt and processing of mail sent                                        Outreach and Capacity Building, 200                              or her individual capacity for a term of
                                                  through the U.S. Postal Service,                                           Jefferson Avenue, Suite 300, Memphis,                            3 years and may be reappointed at the
                                                  commenters are encouraged to submit                                        TN 38103.                                                        discretion of the Secretary. Of the 12
                                                  their comments to OMB via email to:                                                                                                         members first appointed to the HCFAC
                                                                                                                             FOR FURTHER INFORMATION CONTACT:
                                                  OIRA_Submission@omb.eop.gov.                                                                                                                in 2016, 4 were appointed for an initial
                                                                                                                             Marjorie George, Housing Program
                                                  Although commenters are encouraged to                                                                                                       term of 1 year, 4 were appointed for a
                                                                                                                             Technical Specialist, Office of Housing
                                                  send their comments via email,                                                                                                              term of 2 years, and 4 were appointed
                                                                                                                             Counseling, U.S. Department of Housing
                                                  commenters may also fax their                                                                                                               for a term of 3 years. The initial 12
                                                                                                                             and Urban Development, 200 Jefferson
                                                  comments to: 202–395–7285.                                                                                                                  appointments were made by the
                                                                                                                             Avenue, Suite 300, Memphis, TN 38103;
                                                  Commenters may also mail them to:                                                                                                           Secretary on June 1, 2016, and the one-
                                                                                                                             telephone number (901) 544–4228 (this
                                                  Office of Management and Budget,                                                                                                            year appointees terms will expire on
                                                                                                                             is not a toll-free number). Persons who
                                                  Office of Information and Regulatory                                                                                                        May 31, 2017. This notice indicates the
                                                                                                                             have difficulty hearing or speaking may                          Secretary’s decision to reappoint to new
                                                  Affairs, New Executive Office Building,                                    access this number via TTY by calling
                                                  Room 10102, Washington, DC 20503.                                                                                                           three-year terms the original appointees
                                                                                                                             the toll-free Federal Relay Service at                           for consumer, mortgage, and housing
                                                  Summer King,                                                               (800) 877–8339 (toll-free number).                               counseling and to solicit applications to
                                                  Statistician.                                                              Individuals with questions may also                              address a vacancy for real estate due to
                                                  [FR Doc. 2017–11632 Filed 6–5–17; 8:45 am]
                                                                                                                             email HCFAC.application@hud.gov and                              a withdrawal from consideration.
                                                                                                                             in the subject line write ‘‘HCFAC
                                                  BILLING CODE 4162–20–P
                                                                                                                             application question.’’                                          III. Nominations for the Housing
                                                                                                                             SUPPLEMENTARY INFORMATION:
                                                                                                                                                                                              Counseling Federal Advisory
                                                                                                                                                                                              Committee
                                                  DEPARTMENT OF HOUSING AND                                                  I. Background and Authority                                         HUD is seeking nominations for an
                                                  URBAN DEVELOPMENT                                                             The Housing Counseling Federal                                individual whose experience is
                                                                                                                             Advisory Committee (HCFAC) is                                    representative of the real estate industry
                                                  [Docket No. FR–5858–N–07]                                                  congressionally mandated to provide                              to fill one vacancy. Individuals may
                                                                                                                             advice to the Office of Housing                                  nominate themselves. Nominees must
                                                  Solicitation of Appointment
                                                                                                                             Counseling (OHC) (Pub. L. 111–203).                              be U.S. citizens, and cannot be
                                                  Nominations to the Housing
                                                                                                                             The HCFAC provides the OHC valuable                              employees of the U.S. Government. All
                                                  Counseling Federal Advisory
                                                                                                                             advice regarding its mission to provide                          nominees will be serving in their
                                                  Committee
                                                                                                                             individuals and families with the                                ‘‘individual capacity’’ and not in a
                                                  AGENCY:  Office of the Assistant                                           knowledge they need to obtain, sustain,                          ‘‘representative capacity,’’ therefore, no
                                                  Secretary for Housing—Federal Housing                                      and improve their housing through a                              Federally-registered lobbyists may serve
                                                  Commissioner, Department of Housing                                        strong national network of HUD-                                  on the HCFAC.2 Individual capacity, as
                                                  and Urban Development (HUD).                                               approved housing counseling agencies                             clarified by OMB, refers to individuals
                                                  ACTION: Notice of Solicitation of                                          and HUD-certified counselors. The                                who are appointed to committees to
                                                  Appointment Nominations.                                                   HCFAC, however, has no role in
                                                                                                                             reviewing or awarding of OHC housing                                1 See 76 FR 61756 (‘‘Final Guidance on

                                                  SUMMARY:   The Department of Housing                                       counseling grants and procurement                                Appointments of Lobbyists to Federal Boards and
                                                                                                                                                                                              Commissions’’); and 79 FR 47482 (‘‘Revised
                                                  and Urban Development (HUD)                                                contracts. The HCFAC is subject to the                           Guidance on Appointment of Lobbyists to Federal
                                                  established the Housing Counseling                                         requirements of the Federal Advisory                             Advisory Committees, Boards, and Commissions’’);
                                                  Federal Advisory Committee (HCFAC)                                         Committee Act (5 U.S.C. Appendix), 41                            see also https://www.whitehouse.gov/the:press-
mstockstill on DSK30JT082PROD with NOTICES




                                                  on April 14, 2015. This notice invites                                     CFR parts 101–6 and 102–3, and                                   office/presidential-memorandum-lobbyists-agency-
                                                                                                                                                                                              boards-and-commissions (‘‘Lobbyist on Agency
                                                  the public to nominate individuals to                                      Presidential Memorandum ‘‘Final                                  Boards and Commissions’’).
                                                  fill one vacancy representing the real                                     Guidance on Appointments of Lobbyists                               2 See 79 FR 47482 (‘‘Revised Guidance on

                                                  estate industry for a three-year term.                                     to Federal Boards and Commissions,’’                             Appointment of Lobbyists to Federal Advisory
                                                                                                                             dated June 18, 2010, along with any                              Committees, Boards, and Commissions’’) (clarifying
                                                  DATES: Please submit nominations as
                                                                                                                                                                                              that federally registered lobbyists may not serve on
                                                  soon as possible, but no later than June                                   relevant guidance published in the                               advisory committee, board, or Commission in an
                                                  21, 2017.                                                                  Federal Register or otherwise issued by                          ‘‘individual capacity.’’).



                                             VerDate Sep<11>2014       20:52 Jun 05, 2017          Jkt 241001       PO 00000       Frm 00075        Fmt 4703       Sfmt 4703   E:\FR\FM\06JNN1.SGM       06JNN1



Document Created: 2017-06-06 06:21:11
Document Modified: 2017-06-06 06:21:11
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation82 FR 26114 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR